$9.34
N/A
Last update: Nov 10, 9:19 AM
Q32 Bio Inc
QTTBNASDAQ
The average analyst price target for Q32 Bio is $32.67, 249.8% above the current price. Of 12 analysts, 9 rate it Buy and 3 Hold. Targets range from $3 to $95. The latest change came on Oct 12, 2026, when Leerink Partners initiated coverage of Q32 Bio with an Outperform rating and a $40 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 12 Analysts
Rating Trend — Last 9 Months
